These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 441517)

  • 1. Antagonism of cisplatin induced emesis in the dog.
    Gylys JA; Doran KM; Buyniski JP
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):61-8. PubMed ID: 441517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probable involvement of the 5-hydroxytryptamine(4) receptor in methotrexate-induced delayed emesis in dogs.
    Yamakuni H; Sawai H; Maeda Y; Imazumi K; Sakuma H; Matsuo M; Mutoh S; Seki J
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1002-7. PubMed ID: 10688616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study on the control of cisplatin-induced emesis in dogs].
    Ito J; Okada M; Abo T; Okamoto Y; Yamashita T; Takahashi K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):706-10. PubMed ID: 3827261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-induced emesis in the Ferret: a new animal model.
    Florczyk AP; Schurig JE; Bradner WT
    Cancer Treat Rep; 1982 Jan; 66(1):187-9. PubMed ID: 7198011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
    Rudd JA; Ngan MP; Wai MK; King AG; Witherington J; Andrews PL; Sanger GJ
    Neurosci Lett; 2006 Jan; 392(1-2):79-83. PubMed ID: 16182445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs.
    de la Puente-Redondo VA; Tilt N; Rowan TG; Clemence RG
    Am J Vet Res; 2007 Jan; 68(1):48-56. PubMed ID: 17199418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo.
    Gandara DR; Harvey WH; Monaghan GG; Perez EA; Stokes C; Bryson JC; Finn AL; Hesketh PJ
    Semin Oncol; 1992 Aug; 19(4 Suppl 10):67-71. PubMed ID: 1387253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMY-25801, an antiemetic agent free of D2-dopamine receptor antagonist properties.
    Gylys JA; Wright RN; Nicolosi WD; Buyniski JP; Crenshaw RR
    J Pharmacol Exp Ther; 1988 Mar; 244(3):830-7. PubMed ID: 2978041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
    Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Fujiwara Y; Mae M; Fukuda M; Ohe Y; Sasaki S
    Jpn J Clin Oncol; 1989 Mar; 19(1):40-4. PubMed ID: 2921817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis.
    Costall B; Domeney AM; Naylor RJ; Tattersall FD
    Neuropharmacology; 1986 Aug; 25(8):959-61. PubMed ID: 3774121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
    Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA
    Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiemetic activity of butorphanol against cisplatin-induced emesis in ferrets and dogs.
    Schurig JE; Florczyk AP; Rose WC; Bradner WT
    Cancer Treat Rep; 1982 Oct; 66(10):1831-5. PubMed ID: 6889914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiemetic efficacy of prochlorperazine, haloperidol, and droperidol in cisplatin-induced emesis.
    Owens NJ; Schauer AR; Nightingale CH; Golub GR; Martin RS; Williams HM; Schauer PK
    Clin Pharm; 1984; 3(2):167-70. PubMed ID: 6373102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
    Yoshida N; Omoya H; Ito T
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of the clinical efficacy and safety of ondansetron and metoclopramide in the prophylaxis of emesis induced by cancer chemotherapy regimens including cisplatin.
    Advani SH; Gopal R; Dhar AK; Lal HM; Cooverji ND
    J Assoc Physicians India; 1996 Feb; 44(2):127-30. PubMed ID: 10999066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of ondansetron and CP-99,994 to modify behavior and antagonize cisplatin-induced emesis in the ferret.
    Lau AH; Kan KK; Lai HW; Ngan MP; Rudd JA; Wai MK; Yew DT
    Eur J Pharmacol; 2005 Jan; 506(3):241-7. PubMed ID: 15627434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose ondansetron for the prevention of cisplatin-induced emesis: efficacy results.
    Hainsworth JD; Hesketh PJ
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):14-9. PubMed ID: 1485176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advances in the management of chemotherapy-induced emesis].
    Murakami M; Ota K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):401-11. PubMed ID: 3006594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
    Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
    J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.